FILSPARI

This brand name is authorized in United States. It is also authorized in Austria, Estonia, France, Italy, Lithuania.

Active ingredients

The drug FILSPARI contains one active pharmaceutical ingredient (API):

1
UNII 9242RO5URM - SPARSENTAN
 

Sparsentan is a dual endothelin angiotensin receptor antagonist. It is a single molecule that functions as a high affinity, dual-acting antagonist of both the ETAR and AT1R. Endothelin 1, via ETAR, and angiotensin II, via AT1R, mediate processes that lead to IgAN progression through haemodynamic actions and mesangial cell proliferation, increased expression and activity of proinflammatory and profibrotic mediators, podocyte injury, and oxidative stress. Sparsentan inhibits activation of both ETAR and AT1R and thereby reduces proteinuria and slows the progression of kidney disease.

 
Read more about Sparsentan

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 FILSPARI Film-coated tablet MPI, US: SPL/PLR FDA, National Drug Code (US)
 FILSPARI Film-coated tablet MPI, EU: SmPC European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
C09XX01 C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09X Other agents acting on the renin-angiotensin system → C09XX Other agents acting on the renin-angiotensin system
Discover more medicines within C09XX01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
EE Ravimiamet 3083925, 3083936, 3084140
FR Base de données publique des médicaments 63617869, 68110738
IT Agenzia del Farmaco 051214017, 051214029
LT Valstybinė vaistų kontrolės tarnyba 1099663, 1099664
US FDA, National Drug Code 68974-200, 68974-400

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.